Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6978363rdf:typepubmed:Citationlld:pubmed
pubmed-article:6978363lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C0009498lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C0376517lld:lifeskim
pubmed-article:6978363lifeskim:mentionsumls-concept:C1881379lld:lifeskim
pubmed-article:6978363pubmed:issue3lld:pubmed
pubmed-article:6978363pubmed:dateCreated1982-6-14lld:pubmed
pubmed-article:6978363pubmed:abstractTextThymocytes from C57BL/6(B6) mice treated with anti-Thy 1 antiserum without complement in vitro were transferred to lethally irradiated AKR mice. Five days following transfer, the proportion of Thy 1.2(+) cells recovered from the recipient spleen was significantly lower (7%) than that from the control mice which had received untreated cells (64%). the B6 spleen cells were treated in the same manner and transferred with SRBC (T-dependent antigen) or DNP-Ficoll (T-independent antigen) to irradiated syngeneic recipients. The recipients developed a response to SRBC which was significantly lower than that observed in control mice, but showed the same number of plaque-forming cell (PFC) against TNP-SRBC as the control group of mice which had received untreated B6 spleen cells. These results clearly show that in vitro pretreatment of lymphocytes with anti-Thy 1 serum without complement specifically resulted in elimination or inactivation of the T lineage cells in the host environment. The mechanisms of the elimination are discussed in this study.lld:pubmed
pubmed-article:6978363pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6978363pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6978363pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6978363pubmed:languageenglld:pubmed
pubmed-article:6978363pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6978363pubmed:citationSubsetIMlld:pubmed
pubmed-article:6978363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6978363pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6978363pubmed:statusMEDLINElld:pubmed
pubmed-article:6978363pubmed:monthMarlld:pubmed
pubmed-article:6978363pubmed:issn0022-1759lld:pubmed
pubmed-article:6978363pubmed:authorpubmed-author:GoodR ARAlld:pubmed
pubmed-article:6978363pubmed:authorpubmed-author:FernandesGGlld:pubmed
pubmed-article:6978363pubmed:authorpubmed-author:KakinumaMMlld:pubmed
pubmed-article:6978363pubmed:authorpubmed-author:MorikawaKKlld:pubmed
pubmed-article:6978363pubmed:authorpubmed-author:MooeS WSWlld:pubmed
pubmed-article:6978363pubmed:authorpubmed-author:YasumizuRRlld:pubmed
pubmed-article:6978363pubmed:authorpubmed-author:Oh-IshiTTlld:pubmed
pubmed-article:6978363pubmed:issnTypePrintlld:pubmed
pubmed-article:6978363pubmed:day26lld:pubmed
pubmed-article:6978363pubmed:volume49lld:pubmed
pubmed-article:6978363pubmed:ownerNLMlld:pubmed
pubmed-article:6978363pubmed:authorsCompleteYlld:pubmed
pubmed-article:6978363pubmed:pagination315-22lld:pubmed
pubmed-article:6978363pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:meshHeadingpubmed-meshheading:6978363-...lld:pubmed
pubmed-article:6978363pubmed:year1982lld:pubmed
pubmed-article:6978363pubmed:articleTitleSpecific elimination of the T lineage cells: effect of in vitro treatment with anti-Thy 1 serum without complement on the adoptive cell transfer system.lld:pubmed
pubmed-article:6978363pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6978363pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6978363pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6978363lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6978363lld:pubmed